1. 106432499 CTLA‑4抗体FAB在昆虫表达系统中的制备方法
CN
22.02.2017
C07K 16/28 Loading...
C07K 16/28
Loading...
201611045157.1
上海美迪西生物医药股份有限公司
王涛
C07K 16/28
Loading...
本发明涉及CTLA‑4抗体FAB 在昆虫表达系统中的制备方法，包括：（a）将N端分别带有信号肽的Fab片段的轻链与重链的氨基酸序列的基因克隆于带有双启动子的杆状病毒表达载体内构建重组表达载体；（b）将所得的重组表达载体转座至感受态细胞中，筛选重组菌斑，提取重组质粒，并将其转染至昆虫细胞中，得到重组杆状病毒后进一步扩增病毒，并使用病毒感染放大培养的昆虫细胞以表达Fab蛋白，离心收集含Fab蛋白的上清产物；（c）将所得昆虫细胞表达上清首先使用膜包进行超滤浓缩和置换缓冲溶液，然后色谱柱纯化，即可得到全人源单克隆抗体CTLA‑4单抗Fab片段。
2. 105640905 氟硝西泮舌下片制剂及其制备方法
CN
08.06.2016
A61K 9/20 Loading...
A61K 9/20
Loading...
201410723388.8
上海美迪西生物医药有限公司
黄冲
A61K 9/20
Loading...
本发明涉及氟硝西泮舌下片制剂及其制备方法，每1000片舌下片中，氟硝西泮的含量为1～3g，聚乙烯吡咯烷酮K305～10g，聚乙二醇600030～50g，山梨醇30～60g，辛酸癸酸聚乙二醇甘油酯2～10g，硬脂酸镁0.5～2g。本发明利用舌下粘膜未角质化，毛细血管丰富，血流快的特点，针对氟硝西泮经胃肠道给药需要一点时间，而肌内注射相对麻烦的不足，将氟硝西泮制备成舌下片，可使其通过舌下粘膜吸收，通过颈静脉和上腔静脉直接进入血液循环，起效迅速，保证疗效。并且服用时无需用水，置于舌下含化，服用方便，口感好。
3. 104862328 重组阿达木单抗Fab片段在大肠杆菌中的制备方法
CN
26.08.2015
C12N 15/70 Loading...
C12N 15/70
Loading...
201410066863.9
上海美迪西生物医药有限公司
吕立力
C12N 15/70
Loading...
本发明涉及一种重组阿达木单抗Fab片段在大肠杆菌中的制备方法，包括：将由N端分别带有信号肽的Fab片段的重链Fd与轻链的氨基酸序列反转化的基因克隆于带有双启动子的大肠杆菌表达载体内构建重组表达载体；将所得的重组表达载体转化至作为宿主细胞的大肠杆菌获得重组菌，培养所述重组菌并在培养基中加入诱导剂诱导双基因共分泌表达获得经诱导表达的菌体；通过渗透压冲击法提取经诱导表达的菌体的周质蛋白；对所得的周质蛋白进行色谱柱纯化，即可得到阿达木单抗的Fab片段。本发明可制得较高纯度的Fab片段，且能与抗原TNF-α特异性结合，其抑制效果与全抗分子相比无明显的差异，说明该Fab片段保留了原adalimumab抗体具备的抗体性质和特异性。
4. 104345097 生物组织样品中2,3-吲哚醌的浓度的测定方法
CN
11.02.2015
G01N 30/02 Loading...
G01N 30/02
Loading...
201310333153.3
上海美迪西生物医药股份有限公司
陈春麟
G01N 30/02
Loading...
本发明涉及一种生物组织样品中2,3-吲哚醌的浓度的测定方法,包括：生物组织样品前处理步骤：在0～4℃下，按质量比1：（3～5）混合动物给予2,3-吲哚醌后采集的生物组织样品和生理盐水制得生物组织匀浆样品，然后按体积比为1：4混合所述生物组织匀浆样品和内标物甲醇溶液，涡旋30～90秒后离心取上清液；以及通过液相色谱-质谱联用分离经前处理的生物组织样品中的2,3-吲哚醌、并测定生物组织样品中2,3-吲哚醌的浓度的检测步骤。
5. 104133004 血浆样品中2,3-吲哚醌的浓度的测定方法
CN
05.11.2014
G01N 30/02 Loading...
G01N 30/02
Loading...
201310161192.X
上海美迪西生物医药有限公司
陈春麟
G01N 30/02
Loading...
本发明涉及一种血浆样品中2,3-吲哚醌的浓度的测定方法，所述测定方法包括：血浆样品前处理步骤：在0～4℃下，按体积比为1：5混合动物给予2,3-吲哚醌后采集的血浆样品和内标物甲醇溶液，涡旋30～90秒后离心取上清液；以及通过液相色谱-质谱联用对经前处理的血浆样品进行检测的检测步骤，其中液相色谱条件包括：色谱柱为Ascentis，RP-Amide，5μm，50×2.1mm；色谱流动相A为5mM甲酸铵/5mM甲酸水溶液，流动相B为甲醇，流动相A与B的体积百分比分别为55%和45%；质谱条件包括：质谱扫描类型为正离子多反应监测；离子源为电喷雾离子源；雾化气压力为50psi；气体流速为9L/min；毛细管电压为4500V；离子源温度为350℃，内标法定量。
6. 103865914 PDE2催化结构域/PDE2特异性抑制剂复合物的晶体及其生长方法
CN
18.06.2014
C12N 9/99 Loading...
C12N 9/99
Loading...
201210545326.3
上海美迪西生物医药股份有限公司
朱坚
C12N 9/99
Loading...
本发明涉及一种PDE2催化结构域/PDE2特异性抑制剂复合物的晶体及其生长方法，该晶体具有单斜晶系中的空间群P1，该晶体具有晶格常数：α=109.59°±0.1%,β=91.93°±0.1%,γ=90.88°±0.1%。
7. 102274085 Establishment method and application of canine cardiovascular disease model
CN
14.12.2011
A61D 1/00 Loading...
A61D 1/00
Loading...
201110204664.6
Shanghai Medicilon Inc.
Song Haoliang
A61D 1/00
Loading...
The invention relates to an establishment method and application of a canine cardiovascular disease model. The establishment method comprises the following steps: implanting a biological signal remote-measuring system in a dog through surgery; and establishing a cardiovascular disease model in the dog with the biological signal remote-measuring system through surgery. By using the invention, compounds can be effectively and quickly screened, and the mechanisms thereof can be researched; the potential new clinical indications of target compounds can be found; and the data is high in credibility, and the clinical symptoms are more similar to those of humans.
8. 101513533 Method for building models of various diseases in one rat body and application thereof
CN
26.08.2009
A61K 49/00 Loading...
A61K 49/00
Loading...
200810033713.2
Shanghai Medicilon Inc.
Song Haoliang
A61K 49/00
Loading...
The invention provides a method for building models of various diseases in one rat body. By using the method, models of diseases such as myocardial ischemia, cerebral ischemia, hyperlipemia, hyperglycemia, rheumatoid arthritis and the like are built in one rat body at the same time and the building of the models of various diseases can be confirmed by detecting related specific indexes. The method reflects the practical situations of clinic human body diseases and complicating diseases more really, provides a high-efficient method for drug screening, reduces research and development cycle, use of animals and cost, and has a large application value.
9. 101507655 Method for establishing animal models of various diseases in a same dog and use thereof
CN
19.08.2009
A61B 19/00 Loading...
A61B 19/00
Loading...
200810033613.X
Shanghai Medicilon Inc.
Song Haoliang
A61B 19/00
Loading...
The invention provides a method for establishing various disease animal models in vivo in the same dog. Through the method, disease models such as cholelithiasis, myocardial ischemia, hypertension and the like are established simultaneously in vivo of the dog, and the various disease models are verified to be established through detection of related specificity indexes. The method reflects actual conditions of clinical human diseases and complicating diseases more truly, provides a more high-efficiency method for drug screening, shortens development cycle, decreases animal number, reduces research and development cost, and has greater application value. The invention also provides application of the method for establishing the various disease animal models in vivo of the same dog.
10. 1793335 Protein high yield expressing culture medium with celeno methionine mark and appalication thereof
CN
28.06.2006
C12N 1/21 Loading...
C12N 1/21
Loading...
200510110398.5
Meidixi Biological Medicine Co., Ltd., Shanghai
Chen Chunlin
C12N 1/21
Loading...
The invention relates to selenomethionine protein high yield expression culture medium and application. It is made up of M9 salt, amino acid mixture, metal inorganic salt mixture, vitamin, antibiotic, amino acid, L-selenomethionine mixture, and isopropyl thiogalactoside. It can be used to greatly increase selenomethionine signed goal protein expression quantity; the goal proteins such as protein tyrosine phosphatase alpha, dipeptidase IV, beta excreting enzyme, glycogen synthetase kinase 3 beta, transcription factor NF-kB kinase beta, adenylic acid active protein kinase, methionyl amino peptidase, insulin-like growth factor I, protein kinase C, and so on, they can rise expression quantity by 1.3-2.1 times.
11. 1785270 Chinese medicine used for increasing leucocyle, treating thrombocytopenia anl its preparation method
CN
14.06.2006
A61K 36/71 Loading...
A61K 36/71
Loading...
200410089138.X
Shanghai Medixi Biomedicine Co., Ltd.
Gao Jian
A61K 36/71
Loading...
A Chinese medicine for increasing white cells and treating anemia, leukemia and primary thrombocytopenic purpura is prepared from 10 Chinese-medicinal materials including pilose asiabell root, astragalus root, white peony root, Chinese angelica root, etc. Its preparing process is also disclosed.
12. 1736485 Use of vanillin receptor agonist in preparation of product for resisting Alzheimer disease
CN
22.02.2006
A61K 45/00 Loading...
A61K 45/00
Loading...
200510027292.9
Shanghai Medicilon Inc.
Chen Chunlin
A61K 45/00
Loading...
The invention relates to the use of vanillic aldehyde receptor activator in preparing products against Alzheimer's disease, wherein the vanillic aldehyde receptor activator comprises vanillic aldehyde and its derivative, capsaicin analogue and derivatives.

